Statutory Instruments
MEDICINES
Made
20th December 1993
Laid before Parliament
24th January 1994
Coming into force
14th February 1994
The Secretary of State for Health and the Minister for Agriculture, Fisheries and Food, acting jointly in exercise of the powers conferred on them by section 2(2) of the European Communities Act 1972(1), being designated for the purposes of that section in relation to medicinal products(2), hereby make the following Regulations:
1.—(1) These Regulations may be cited as the Medicines Act 1968 (Amendment) Regulations 1994 and shall come into force on 14th February 1994.
(2) In these Regulations “the Act” means the Medicines Act 1968(3) and a reference to a numbered section in these Regulations is a reference to the section of the Act which bears that number.
2.—(1) Section 7(4) (general provisions as to dealing with medicinal products) is amended as follows.
(2) After subsection (2), there is inserted—
“(2A) The restrictions imposed by subsection (2) of this section shall not apply where the medicinal product concerned is a homoeopathic medicinal product in respect of which a certificate of registration has been granted.
(2B) In relation to a homoeopathic medicinal product to which the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994(5) apply but in respect of which no certificate of registration has been granted, the references in subsection (2) of this section to the activities of sale or supply and of procuring the sale or supply respectively shall be taken to include references to any activity which amounts to placing such a product on the market within the meaning of Council Directive 92/73/EEC(6) of 22 September 1992.”.
(3) In subsection (6A), paragraph (c) and the word “or” immediately preceding it are omitted.
(4) In subsection (7), before the definition of “proprietary medicinal product” there is inserted—
““certificate of registration” means a certificate granted under the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994;
“homoeopathic medicinal product” means any medicinal product (which may contain a number of principles) prepared from products, substances or compositions called homoeopathic stocks in accordance with a homoeopathic manufacturing procedure described by the European Pharmacopoeia or, in the absence thereof, by any pharmacopoeia used officially in a member State;”.
3.—(1) Section 8(7) (provisions as to manufacture and wholesale dealing) is amended as follows.
(2) In subsection (4), paragraph (b) and the word “or” immediately preceding it are omitted.
(3) In subsection (6), before “proprietary medicinal product” there is inserted “homoeopathic medicinal product,”.
4. In section 24 (duration and renewal of licence)(8)—
(a)in subsection (1A) after “obligation” there is inserted “(other than an obligation under the 1992 Directive)”;
(b)in subsection (3)(c) after “this Act” there is inserted “and any Community obligation under the 1965 Directive or the 1992 Directive”; and
(c)after subsection (6) there is inserted—
“(7) In this section “the 1992 Directive” means Council Directive 92/27/EEC(9) of 31 March 1992 on the labelling of medicinal products for human use and on package leaflets.”.
5.—(1) Section 28(10) (general power to suspend, revoke or vary licences) is amended as follows.
(2) In subsection (3)—
(a)at the beginning there is inserted “Subject to subsection (3A) of this section”; and
(b)in paragraph (j) after “relates” there is inserted “(other than products to which Chapters II to V of the 1965 Directive apply)”.
(3) After subsection (3) there is inserted—
“(3A) Where a product licence relates to a product to which Chapters II to V of the 1965 Directive apply, the power conferred by this section to suspend a licence shall be exercisable in relation to the licence on the ground that—
(a)any of the provisions contained in regulations made under section 85 (labelling and marking of containers and packages) or 86 (leaflets) of this Act, or
(b)section 86(4),
has to a material extent been contravened in relation to the product by the holder of the licence or by a person procured by him to manufacture or assemble the product.”.
(4) The amendments made by this regulation have effect only in relation to licences granted or renewed after the coming into force of these Regulations.
6.—(1) After section 86(3) (leaflets), there is inserted—
“(4) No person shall, in the course of a business carried on by him, supply a product to which Chapters II to V of the Directive apply, unless—
(a)a leaflet enclosed in, or supplied with, the container or package of the product, or
(b)the container or package itself,
contains the particulars which a leaflet relating to the product is required by regulations under subsection (1) of this section to contain, and does so in the manner required by such regulations.”.
(2) The amendment made by this regulation has effect only in relation to licences granted or renewed after the coming into force of these Regulations.
7. In section 91(1) (offences under Part V etc.)(11), after “section 86(3)”, there is inserted “or (4)”.
8. In section 132(1)(12) (general interpretation), in the definition of “the 1965 Directive”, for “and 89/381/EEC(h);”there is substituted “, 89/381/EEC(h) and Article 9(1) of Council Directive 92/73/EEC;”(13).
Signed by authority of the Secretary of State for Health
Tom Sackville
Parliamentary Under-Secretary of State
Department of Health
16th December 1993
In witness whereof the Official Seal of the Minister of Agriculture, Fisheries and Food was hereunto affixed on 20th December 1993
L.S.
Gillian Shephard
(This note is not part of the Regulations)
These Regulations further amend the Medicines Act 1968 (“the Act”) to implement in part Council Directive 92/73/EEC (“the Homoeopathic Directive”) (OJ L297, 13.10.92, p. 8) which widens the scope of Directives 65/65/EEC (OJ No.22, 9.2.1965, p. 369/65) and 75/319/EEC (OJ No. L147, 9.6.1975, p. 13) on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products and laying down additional provisions on homoeopathic medicinal products and Council Directive 92/27/EEC (OJ No. L113, 30.4.92, p. 8) (“the Labelling Directive”) which concerns the labelling of, and leaflets to be provided with, medicinal products.
Regulation 2 amends section 7 of the Act by adding two new subsections, (2A) which provides that as regards a product in respect of which a certificate of registration has been granted, no requirement arises under section 7, and (2B) which expands the activities caught by section 7(2) where there is no licence or certificate so as to include placing such a product on the market (see Article 7 of the Homoeopathic Directive). Definitions of the terms “certificate of registration” and “homoeopathic medicinal product” have also been inserted.
Regulation 3 amends section 8 of the Act by removing the exemption from the requirement to obtain a wholesale dealer’s licence for homoeopathic medicinal products for human use which have been imported but not consigned from a member State of the European Community (Article 3 of the Homoeopathic Directive).
Regulation 4 amends section 24 of the Act so as to ensure that the requirements of the Labelling Directive are properly taken into account when an application for renewal of a licence under Part II of the Act is considered (Article 10(2) of the Labelling Directive).
Regulation 5 amends section 28 of the Act by providing for the suspension of a product licence for a medicinal product to which Chapters II to V of the 1965 Directive apply where there is a material contravention of section 86(4) of the Act or of regulations made under the Act concerning leaflets and labelling (Article 11 of the Labelling Directive).
Regulation 6 inserts a new subsection (4) in section 86 of the Act to require, in accordance with Article 6 of the Labelling Directive, that no medicinal product to which Chapters II to V of the 1965 Directive apply is to be supplied unless a leaflet containing specified information is enclosed in, or supplied with, the package, or the package itself carries that information.
Regulation 7 amends section 91 of the Act; the amendments have effect only to provide that contravention of section 86(4) is an offence.
Regulation 8 makes a consequential amendment to the definition of the 1965 Directive in section 132(1).
Other parts of the Homoeopathic Directive are implemented by the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994 (S. I.1994/105), the Medicines (Labelling and Leaflets) Amendment Regulations 1994 (S. I.1994/104) and the Medicines (Standard Provisions for Licences and Certificates) Amendment Regulations 1994 (S. I.1994/103). Other parts of the Labelling Directive are implemented by the Medicines (Labelling) Amendment Regulations 1992 (S. I.1992/3273) and the Medicines (Leaflets) Amendment Regulations 1992 (S. I.1992/3274).
S.I. 1972/1811.
Subsection (5) of section 7 was amended by regulation 2(2) of S.I. 1977/1050 and regulation 3 of (N.I.) S.R.1977 No.170, regulation 2(2) of S.I.1983/1724 and regulation 2 of S.I.1992/604 (which also inserted subsections (6A) and (6B)).
S.I. 1994/105.
OJ No. L 297, 13.10.92, p. 8.
Subsections (3) and (4) of section 8 were amended by regulation 3(2) of S.I.1977/1050 and regulation 4 of (N.I.) S.R.1977 No.170, regulation 3 of S.I.1983/1724, regulation 3(2) and (3) of S.I. 1992/604 (which also inserted subsections (5) and (6)) and regulation 2 of S.I.1993/834 (which also inserted subsections (3A), (3B), (3C), (7) and (8)).
Section 24 was amended by regulation 4(4) of the Medicines (Medicines Act 1968 Amendment) Regulations 1977 (S.I.1977/1050) and regulation 5(4) of (N.I.) S.R.1977 No.150, and applied by regulation 2 of, and the Schedule to, the Medicines Act 1968 (Application to Radiopharmaceutical associated Products) Regulations 1992 (S.I. 1992/605).
OJ No. L 113, 30.4.92, p. 8.
Section 28 was amended by regulation 2(2) of the Medicines (Medicines Act 1968 Amendment) Regulations 1975 (S.I.1975/1169), S.R.& O. (N.I.) 1975/197, regulation 4(5) of the Medicines (Medicines Act 1968 Amendment) Regulations 1977 (S.I.1977/1050), regulation 5(5) of (N.I.) S.R.No.170 and by paragraph 3(2) of Schedule 1 to the Animal Health and Welfare Act 1984 (c. 40).See also the Medicines Act (Application to Radiopharmaceutical-associated Products) Regulations 1992 (S.I.1992/605).
Section 91(1) was amended by section 32(2) of the Magistrates' Court Act 1980 (c. 43).See also the Criminal Penalties etc.(Increase) Order 1984 (S.I.1984/447) and the Medicines Act (Application to Radiopharmaceutical-associated Products) Regulations 1992 (S.I. 1992/605).
The definition of “the 1965 Directive” was inserted into section 132(1) by regulation 3 of S.I.1992/3271.
OJ No. L297, 13.10.92, p. 8.